Literature DB >> 23120443

Head and Neck Squamous Cell Cancer: Biology (II) and Translational Methods.

Anupam Mishra1, Amita Pandey, Xiaolin Nong.   

Abstract

The essential steps implicated in carcinogenesis are acquisition of autonomous proliferative signaling; inhibition of growth inhibitory signals; evasion of apoptosis; immortalization; angiogenesis; tissue invasion and metastasis. A considerable progress in understanding the process of carcinogenesis has further stimulated the high throughput translational methods and systems biology approach to revolutionize this field of cancer biology. The era of molecular targeted therapy has dawned and would soon replace the more 'toxic' classical 'broad-spectrum' cancer chemotherapy. This review summarises the steps of carcinogenesis and the concepts involved in translational methods, systems-biology and molecular targeted therapy.

Entities:  

Keywords:  Carcinogenesis; Molecular targeted therapy; Systems-biology

Year:  2007        PMID: 23120443      PMCID: PMC3452106          DOI: 10.1007/s12070-007-0071-9

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  41 in total

1.  Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.

Authors:  C C Bancroft; Z Chen; G Dong; J B Sunwoo; N Yeh; C Park; C Van Waes
Journal:  Clin Cancer Res       Date:  2001-02       Impact factor: 12.531

2.  Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.

Authors:  R J Bova; D I Quinn; J S Nankervis; I E Cole; B F Sheridan; M J Jensen; G J Morgan; C J Hughes; R L Sutherland
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

Review 3.  New concepts on the role of human papillomavirus in cell cycle regulation.

Authors:  S M Syrjänen; K J Syrjänen
Journal:  Ann Med       Date:  1999-06       Impact factor: 4.709

4.  Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.

Authors:  O Gallo; I Chiarelli; V Boddi; C Bocciolini; L Bruschini; B Porfirio
Journal:  Int J Cancer       Date:  1999-12-22       Impact factor: 7.396

5.  Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer.

Authors:  F Riedel; K Götte; W Bergler; W Rojas; K Hörmann
Journal:  Head Neck       Date:  2000-03       Impact factor: 3.147

6.  Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma.

Authors:  T Nakashima; G L Clayman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-08

7.  Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Authors:  J Rubin Grandis; M F Melhem; W E Gooding; R Day; V A Holst; M M Wagener; S D Drenning; D J Tweardy
Journal:  J Natl Cancer Inst       Date:  1998-06-03       Impact factor: 13.506

8.  Frequent p53 mutations in head and neck cancer.

Authors:  K D Somers; M A Merrick; M E Lopez; L S Incognito; G L Schechter; G Casey
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

9.  EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance.

Authors:  M Maurizi; G Scambia; P Benedetti Panici; G Ferrandina; G Almadori; G Paludetti; R De Vincenzo; M Distefano; D Brinchi; G Cadoni
Journal:  Int J Cancer       Date:  1992-12-02       Impact factor: 7.396

10.  p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.

Authors:  I Ganly; D S Soutar; R Brown; S B Kaye
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.